Assembly Biosciences director granted 8,000 options
Assembly Biosciences director Lisa Johnson-Pratt received a grant of stock options for 8,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Assembly Biosciences director Lisa Johnson-Pratt received a grant of stock options for 8,000 shares of common stock. The options have an exercise price of $24.11 per share and expire on June 4, 2036. They vest, assuming continuous service, on the earlier of June 4, 2027 or the company’s 2027 annual stockholder meeting. Following this grant, she holds 8,000 stock options directly.
Insider Trade Summary
Grant/Award: 8,000 shares
Grant/Award
1 txn
Insider
Johnson-Pratt Lisa
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 8,000 contracts (Direct)
Footnotes (1)
- F1. Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders.
Key Figures
Options granted: 8,000 options
Exercise price: $24.11 per share
Underlying shares: 8,000 shares
+2 more
5 metrics
Options granted
8,000 options
Stock Option (right to buy) granted to director
Exercise price
$24.11 per share
Conversion or exercise price of granted options
Underlying shares
8,000 shares
Common Stock underlying the options
Expiration date
June 4, 2036
Option expiration date
Vesting date trigger
Earlier of June 4, 2027 or 2027 annual meeting
Vesting condition assuming continuous service
Key Terms
Stock Option (right to buy), Grant, award, or other acquisition, exercise price, vest, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 24.1100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"the date of the Issuer's 2027 annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ASMB director Lisa Johnson-Pratt report?
Lisa Johnson-Pratt reported a grant of stock options for 8,000 shares. These are derivative securities giving her the right to buy Assembly Biosciences common stock at a fixed price, subject to a vesting schedule and expiration date.
How many Assembly Biosciences (ASMB) options were granted in this Form 4?
The filing reports a grant of 8,000 stock options. Each option relates to one share of Assembly Biosciences common stock, so the award covers 8,000 underlying shares, all held directly by the reporting person after the transaction.
What is the exercise price of the ASMB stock options granted?
The stock options have an exercise price of $24.11 per share. This is the price at which Lisa Johnson-Pratt can purchase Assembly Biosciences common stock once the options vest and before they expire, if she chooses to exercise them.
When do Lisa Johnson-Pratt’s ASMB options vest according to the Form 4?
The options vest upon the earlier of June 4, 2027 or the 2027 annual meeting. Vesting requires continuous service through that date, after which the options become exercisable, subject to their expiration in 2036.
When do the Assembly Biosciences stock options reported in this Form 4 expire?
The options expire on June 4, 2036. After that expiration date, any unexercised options become worthless, so the holder must exercise vested options before or on that date to purchase common shares.
Is the ASMB Form 4 transaction an open-market buy or compensation grant?
The transaction is a compensation-related grant, not an open-market purchase. It is coded as a “Grant, award, or other acquisition” of derivative securities, reflecting options awarded for service rather than shares bought on the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
